膜转运/离子通道
CAS号：873054-44-5
品名：N-(2,4-二叔丁基-5-羟基苯基)-1,4-二氢-4-氧代-3-喹啉甲酰胺ivacaftor
中文别名：N-(2,4-二叔丁基-5-羟基苯基)-1,4-二氢-4-氧代-3-喹啉甲酰胺
英文别名：UNII-1Y740ILL1Z;VX770,VX770,Ivacaftor;N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide;N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;Ivacaftor;N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide;[14C]-Ivacaftor;N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxaraide;Ivacaftor(VX-770);N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide;Kalydeco;VX770;
分子式：C24H28N2O3
分子量：392.491
精确质量：392.21
Psa：85.68
MDL号：MFCD17171361
密度：1.187 g/cm3
沸点：550.4ºC at 760 mmHg
闪点：286.7ºC
简介：Ivacaftor(tradenameKalydeco,developedasVX-770)isadrugusedtotreatcysticfibrosisinpeoplewithcertainmutationsinthecysticfibrosistransmembraneconductanceregulator(CFTR)gene,whoaccountfor4–5%casesofcysticfibrosis,andisincludedinacombinationdrug,lumacaftor/ivacaftor,whichisusedtotreatpeoplewithcysticfibrosiswhohavetheF508delmutationinCFTR.
